iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Sees Significant Decrease in Short Interest

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) saw a significant decrease in short interest in September. As of September 30th, there was short interest totaling 2,277 shares, a decrease of 93.5% from the September 15th total of 35,162 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 10,460 shares, the short-interest ratio is presently 0.2 days.

iShares LifePath Target Date 2045 ETF Stock Performance

Shares of ITDE traded up $0.28 during trading hours on Friday, reaching $40.39. The stock had a trading volume of 5,548 shares, compared to its average volume of 13,580. iShares LifePath Target Date 2045 ETF has a 12 month low of $34.81 and a 12 month high of $41.23. The stock has a market capitalization of $107.44 million, a PE ratio of 20.03 and a beta of 0.82. The company’s 50-day moving average is $40.56 and its two-hundred day moving average is $39.46.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.